As CRP reflects systemic inflammation and LDH reflects tumor burden and metabolic activity [13–15], lower values of these markers suggest that patients in the High-Alb group may have relatively attenuated inflammation and tumor progression. This evidence concerns the gene CRP and neoplasm.